MondayJun 22, 2026 9:30 am

QualityStocksNewsBreaks – M-tron Industries, Inc. (NYSE American: MPTI) Secures $6.8 Million Follow-On Defense Order for C-UAS Radar Programs

M-tron Industries (NYSE American: MPTI) announced a $6.8 million follow-on order from a U.S. Department of Defense contractor supporting multiple counter-unmanned aircraft system ("C-UAS") radar programs. The order includes several products, including high-performance oven-controlled crystal oscillators, with work scheduled to be performed in Orlando, Florida, through 2027. The company said the radar program is gaining traction across U.S. defense procurement channels and federal civilian agencies and is expected to remain in production beyond 2030. Mtron noted the award reflects continued demand for its precision RF components used in defense and aerospace applications, including radar, electronic warfare, communications, drones, autonomous vehicles,…

Continue Reading

MondayJun 22, 2026 9:20 am

QualityStocksNewsBreaks – Knight Therapeutics Inc. (TSX: GUD) Repays Credit Facility Used to Fund Paladin Acquisition

This article has been disseminated on behalf of Knight Therapeutics Inc. and may include paid advertising. Knight Therapeutics (TSX: GUD) announced that it has repaid all outstanding amounts under its revolving credit facility with National Bank of Canada and a syndicate of lenders. The company had drawn $60 million from the facility in June 2025 to help finance its acquisition of Paladin. Knight said the repayment was funded through strong cash flow generated by its operations in Canada and Latin America. The revolving credit facility continues to provide borrowing capacity of up to US$100 million, with an additional US$100 million…

Continue Reading

MondayJun 22, 2026 9:00 am

HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

The seriousness of coronary artery disease continues to intensify as populations age and cardiovascular risk factors become more common. HeartBeam announced the launch of a pilot study focused on evaluating its on-demand 12-lead ECG patch in detecting coronary artery disease and inadequate blood flow and oxygen supply to tissue, or ischemia. The study represents a significant step in the development of the HeartBeam patch, which has the potential to disrupt the $2 billion long-term continuous monitor and mobile cardiac telemetry (“MCT”) markets. Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of…

Continue Reading

MondayJun 22, 2026 9:00 am

QualityStocksNewsBreaks – Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) Launches Chemical Risk Assessment Initiative, Appoints Stanford Chemist as Scientific Advisor

This article has been disseminated on behalf of Redwood AI Corp. and may include paid advertising. Redwood AI (CSE: AIRX) (OTCQB: RDWCF) (Frankfurt: Y0N, WKN: A422EZ) has launched development of a Chemical Risk Assessment Module within its Reactosphere platform and appointed Stanford University chemistry professor Dr. Noah Burns as a scientific advisor. The initiative is designed to strengthen chemical safety, hazardous material screening and responsible AI-enabled chemistry research through collaboration with academic and industry participants. The company said the new module will support the development of chemical risk datasets, safety assessment tools and user feedback mechanisms that can enhance both its…

Continue Reading

ThursdayJun 18, 2026 2:07 pm

QualityStocksNewsBreaks – Numa Numa Resources Inc. Advancing Responsible Mining Strategy in Bougainville

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Numa Numa Resources was featured in a recent article that discussed its efforts to advance mining development in Bougainville in a way that aligns with local priorities and long-term economic goals. “Small islands with large mineral reserves often face a defining question: Can the wealth beneath the ground help fund political and economic independence above it? In Bougainville, Numa Numa Resources is working within this dynamic, positioning itself in a region where resource development and aspirations for self-determination are closely intertwined,” reads the publication. “Numa Numa emphasizes collaboration with landowners…

Continue Reading

ThursdayJun 18, 2026 1:01 pm

QualityStocksNewsBreaks – MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Positions AI Voice Analysis as Scalable Testing Alternative

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF) was featured in a recent TechMediaWire Podcast, where CEO Justin Hanka discussed the company’s plans to commercialize AI-powered voice analysis technology designed to detect alcohol and drug intoxication through non-invasive speech assessment. During the interview, Hanka explained that the company has built prediction models using more than 50 million data points collected through years of clinical research, enabling the identification of intoxication indicators associated with alcohol and drug use. MindBio believes its technology offers a scalable alternative to traditional testing methods that…

Continue Reading

ThursdayJun 18, 2026 12:29 pm

QualityStocksNewsBreaks – Why Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Is ‘One to Watch’

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. A clinical-stage oncology company , Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is focused on advancing a new class of DNA Damage Response (“DDR”) therapies and developing artificial intelligence-driven precision oncology solutions. “The company is leading the development of Polynucleotide Kinase Phosphatase (‘PNKP’) inhibitors, an emerging category of DDR therapeutics designed to target DNA repair pathways involved in cancer survival and resistance,” reads a recent article. “Through its dual-platform approach, Onco-Innovations combines proprietary drug development with AI-enabled technologies intended to support oncology research, clinical development, patient stratification and evidence generation.” To…

Continue Reading

ThursdayJun 18, 2026 11:44 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Receives Delivery of 5MW Pre-Production Texatron™ Fusion Engine™

American Fusion (OTC: AMFN) announced that members of its engineering and leadership teams have arrived in Texas to accept delivery of the company's 5MW Pre-Production Texatron™ Fusion Engine™, a milestone that follows the completion of final fabrication and modification activities. The system is expected to be transported to the Dallas-Fort Worth Metroplex, where installation, commissioning and testing activities are planned as the company advances development of its proprietary aneutronic fusion technology. American Fusion said the 5MW pre-production system represents the culmination of nine prototype generations and is expected to serve as the primary platform for future testing, validation and development efforts. The company also noted that…

Continue Reading

ThursdayJun 18, 2026 11:15 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies High-Priority Rare Earth Targets at Ontario’s Hopkins Project as Global Demand for Critical Minerals Accelerates

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals has completed a desktop study identifying multiple high-priority rare earth element (“REE”) exploration targets at its Hopkins REE Project in northeastern Ontario. The study integrated geological, geophysical, geochemical, and historical datasets to define structurally controlled areas that may host REE mineralization. Powermax plans a phased exploration program including mapping, sampling, airborne surveys, and potentially drilling, subject to exploration results and permits. The company continues to build a North American portfolio of rare earth assets across Canada and the United States as rise…

Continue Reading

ThursdayJun 18, 2026 10:30 am

Earth Science Tech Inc. (ETST) Signals Strong Confidence with Aggressive Q1 Share Buybacks

Aggressive repurchase of its own stock by Earth Science Tech, a growing holding company focused on various aspects of the healthcare industry,  reflects management’s growing internal confidence in the company’s future trajectory. Over 3 million shares of common stock have been repurchased in current fiscal quarter, a significant acceleration in buybacks. Reduction in share dilution can consolidate existing equity and potentially boost earnings per share (“EPS”). Earth Science Tech (OTC: ETST) is capturing the attention of the micro-cap market following a significant acceleration of its share repurchase program. Recent market data indicates that the company is aggressively buying back its…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered